Annual report pursuant to Section 13 and 15(d)

Business Combinations - Additional Information (Detail)

v3.22.4
Business Combinations - Additional Information (Detail) - USD ($)
 1 Months Ended 12 Months Ended
Aug. 11, 2022
Jun. 10, 2022
Mar. 01, 2022
Sep. 14, 2021
Jul. 31, 2021
Sep. 30, 2022
Aug. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]                    
Estimated useful lives   3 years                
Tax rate               (9.93%) (4.36%)  
Deferred tax assets, valuation allowance               $ 81,051,000 $ 81,784,000 $ 65,110,000
Revenue               149,728,000 115,305,000  
Net loss               (25,557,000) $ (64,672,000)  
Israeli [Member]                    
Business Acquisition [Line Items]                    
Tax rate         23.00%   12.00%      
Minimum [Member]                    
Business Acquisition [Line Items]                    
Contingent earnout           $ 10,825,000        
VSL Acquisition [Member]                    
Business Acquisition [Line Items]                    
Total consideration $ 1,952,000                  
Cash payment 1,700,000                  
Deferred consideration 252,000                  
VSL Acquisition [Member] | Developed Technology [Member]                    
Business Acquisition [Line Items]                    
Total intangible assets $ 1,500,000                  
Estimated useful lives 3 years                  
VSL Acquisition [Member] | General and Administrative Expense [Member]                    
Business Acquisition [Line Items]                    
Acquisition related expenses $ 272,000                  
VocaliD [Member]                    
Business Acquisition [Line Items]                    
Total consideration   $ 3,384,000                
Cash payment   1,609,000                
Net working capital adjustment   (10,000)                
Deferred consideration   1,785,000                
Tax deductible goodwill, acquisition   0                
Deferred tax liability   663,000                
VocaliD [Member] | Developed Technology [Member]                    
Business Acquisition [Line Items]                    
Total intangible assets   2,700,000                
VocaliD [Member] | General and Administrative Expense [Member]                    
Business Acquisition [Line Items]                    
Acquisition related expenses   $ 200,000                
March 2022 Acquisition [Member]                    
Business Acquisition [Line Items]                    
Total consideration     $ 5,881,000              
Cash payment     1,500,000              
Total intangible assets     2,700,000              
Equity consideration at closing     1,929,000              
Settlement of pre-existing receivable     976,000              
Acquired cash     684,000              
Contingent earnout     3,015,000              
Transaction cost     270,000              
Net working capital adjustment     37,000              
Deferred consideration     2,707,000              
Tax deductible goodwill, acquisition     $ 2,842,000              
March 2022 Acquisition [Member] | Minimum [Member]                    
Business Acquisition [Line Items]                    
Estimated useful lives     3 years              
March 2022 Acquisition [Member] | Maximum [Member]                    
Business Acquisition [Line Items]                    
Estimated useful lives     10 years              
March 2022 Acquisition [Member] | General and Administrative Expense [Member]                    
Business Acquisition [Line Items]                    
Acquisition related expenses     $ 270,000              
Pandologic Ltd [Member]                    
Business Acquisition [Line Items]                    
Business acquisition, effective date of acquisition       Sep. 14, 2021            
Business acquisition, percentage of ownership interests acquired       100.00%            
Business acquisition, name of acquired entity       PandoLogic Ltd            
Business acquisition, date of acquisition agreement       Jul. 21, 2021            
Total consideration       $ 135,563,000            
Cash payment       58,733,000            
Total intangible assets       92,000,000            
Equity consideration at closing       31,500,000            
Contingent earnout       44,900,000            
Net working capital adjustment       5,818,000            
Contingent earnout       39,512,000            
Deferred tax liability       $ 12,686,000       0    
Deferred tax assets               0    
Goodwill not deductible for tax purposes               33,111,000    
Deferred tax assets, valuation allowance               $ 0    
Pandologic Ltd [Member] | Israeli [Member]                    
Business Acquisition [Line Items]                    
Tax rate       12.00%       23.00%    
Pandologic Ltd [Member] | Minimum [Member]                    
Business Acquisition [Line Items]                    
Estimated useful lives     4 years              
Pandologic Ltd [Member] | Maximum [Member]                    
Business Acquisition [Line Items]                    
Estimated useful lives     7 years              
Pandologic Ltd [Member] | Contingent Consideration                    
Business Acquisition [Line Items]                    
Contingent earnout       $ 39,512,000            
Pandologic Ltd [Member] | Common Stock [Member]                    
Business Acquisition [Line Items]                    
Consideration equity interest issued number of shares               352,330    
Pandologic Ltd [Member] | Developed Technology [Member]                    
Business Acquisition [Line Items]                    
Total intangible assets       $ 20,000,000            
Estimated useful lives       4 years            
Pandologic Ltd [Member] | General and Administrative Expense [Member]                    
Business Acquisition [Line Items]                    
Acquisition related expenses       $ 2,161,000            
Pandologic Ltd [Member] | Recognized In Compensation Expense Within General And Administrative Expense [Member]                    
Business Acquisition [Line Items]                    
Contingent earnout       5,388,000            
Stock Purchase Agreement [Member] | VSL Acquisition [Member]                    
Business Acquisition [Line Items]                    
Business acquisition, effective date of acquisition Aug. 11, 2022                  
Business acquisition, name of acquired entity VSL                  
Total consideration $ 1,952,000                  
Cash payment 1,700,000                  
Deferred cash payment 300,000                  
Deferred consideration $ 252,000                  
Stock Purchase Agreement [Member] | VocaliD [Member]                    
Business Acquisition [Line Items]                    
Business acquisition, effective date of acquisition   Jun. 10, 2022                
Business acquisition, percentage of ownership interests acquired   100.00%                
Business acquisition, name of acquired entity   VocaliD                
Business acquisition, date of acquisition agreement   Jun. 10, 2022                
Total consideration   $ 3,384,000                
Cash payment   1,609,000                
Deferred cash payment   2,000,000                
Net working capital adjustment   10,000                
Deferred consideration   $ 1,785,000                
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member]                    
Business Acquisition [Line Items]                    
Business acquisition, effective date of acquisition     Mar. 01, 2022              
Business acquisition, percentage of ownership interests acquired     100.00%              
Business acquisition, date of acquisition agreement     Mar. 01, 2022              
Total consideration     $ 5,881,000              
Cash payment     1,500,000              
Deferred cash payment     3,000,000              
Settlement of pre-existing receivable     976,000              
Acquired cash     684,000              
Net working capital adjustment     37,000              
Deferred consideration     2,707,000              
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member] | Maximum [Member]                    
Business Acquisition [Line Items]                    
Contingent earnout consideration     4,500,000              
Securities Purchase Agreement [Member] | March 2022 Acquisition [Member] | Common Stock [Member]                    
Business Acquisition [Line Items]                    
Equity consideration at closing     $ 1,929,000              
Consideration equity interest issued number of shares     116,550              
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member]                    
Business Acquisition [Line Items]                    
Total consideration       135,563,000            
Cash payment       58,733,000            
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member] | Maximum [Member]                    
Business Acquisition [Line Items]                    
Contingent earnout consideration       65,000,000            
Agreement and Plan of Merger [Member] | Pandologic Ltd [Member] | Common Stock [Member]                    
Business Acquisition [Line Items]                    
Equity consideration at closing       $ 31,500,000            
Consideration equity interest issued number of shares       1,704,822